<DOC>
	<DOCNO>NCT00297180</DOCNO>
	<brief_summary>GW869682 cause glucose excreted urine . The purpose study see whether enough calorie glucose excrete urine cause weight loss .</brief_summary>
	<brief_title>Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 Weeks</brief_title>
	<detailed_description />
	<mesh_term>Weight Loss</mesh_term>
	<criteria>Inclusion criterion : Have BMI within range 30.0 40.0kg/m2 , inclusive . Females meet criterion must physiologically incapable become pregnant ( ie. , surgically sterilize , postmenopausal per protocol definition ) . Exclusion criterion : History eat disorder . Recent history weight loss gain . Had gastrointestinal surgery treatment obesity . Type 1 type 2 diabetes mellitus . Have positive urine drug screen . Have liver disease . Have hepatitis B , hepatitis C , HIV antibody . Have thyroid disorder control medication . Have disease ( heart , liver , blood , nervous system , kidney disease , cancer ) . Are unable participate exercise program . Have use weight loss drug within 3 month start study . Are currently use warfarin , digoxin , oral anticoagulant ( aspirin nonsteroidal antiinflammatory drug ) , oral injectable corticosteroid ( inhale &amp; intranasal corticosteroid permit ) , antiretroviral medication . Used investigational drug device study within 30 day prior 1st dose study medication . High low blood pressure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>hunger</keyword>
	<keyword>obesity</keyword>
	<keyword>sodium-dependent glucose transporter</keyword>
	<keyword>GW869682</keyword>
	<keyword>body composition</keyword>
	<keyword>SGLT2 inhibitor</keyword>
	<keyword>weight loss</keyword>
</DOC>